ATE191088T1 - Verfahren zum nachweis einer rinderdiarrhoe- virusinfektion, für ein durch eine infektion mit diesem virus induziertes eiweiss kodierende nukleotidsequenz, sowie daraus abgeleitete rekombinante eiweisse und antigene - Google Patents

Verfahren zum nachweis einer rinderdiarrhoe- virusinfektion, für ein durch eine infektion mit diesem virus induziertes eiweiss kodierende nukleotidsequenz, sowie daraus abgeleitete rekombinante eiweisse und antigene

Info

Publication number
ATE191088T1
ATE191088T1 AT92401600T AT92401600T ATE191088T1 AT E191088 T1 ATE191088 T1 AT E191088T1 AT 92401600 T AT92401600 T AT 92401600T AT 92401600 T AT92401600 T AT 92401600T AT E191088 T1 ATE191088 T1 AT E191088T1
Authority
AT
Austria
Prior art keywords
infection
virus
bvd
nucleotide sequence
protein
Prior art date
Application number
AT92401600T
Other languages
English (en)
Inventor
Danielle Helene Je Vandenbergh
Corine Martine Therese Lecomte
Gilles-Emile Chappuis
Jean-Jacques Pin
Original Assignee
Merial Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Sas filed Critical Merial Sas
Application granted granted Critical
Publication of ATE191088T1 publication Critical patent/ATE191088T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT92401600T 1991-06-11 1992-06-10 Verfahren zum nachweis einer rinderdiarrhoe- virusinfektion, für ein durch eine infektion mit diesem virus induziertes eiweiss kodierende nukleotidsequenz, sowie daraus abgeleitete rekombinante eiweisse und antigene ATE191088T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9107076A FR2677767B1 (fr) 1991-06-11 1991-06-11 Procede de detection de l'infection par le virus de la diarrhee bovine, sequence nucleotidique codant pour une proteine induite par l'infection par ce virus et proteines et antigenes recombinants s'y rapportant .

Publications (1)

Publication Number Publication Date
ATE191088T1 true ATE191088T1 (de) 2000-04-15

Family

ID=9413682

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92401600T ATE191088T1 (de) 1991-06-11 1992-06-10 Verfahren zum nachweis einer rinderdiarrhoe- virusinfektion, für ein durch eine infektion mit diesem virus induziertes eiweiss kodierende nukleotidsequenz, sowie daraus abgeleitete rekombinante eiweisse und antigene

Country Status (11)

Country Link
US (2) US5665534A (de)
EP (1) EP0518756B1 (de)
JP (1) JP3415635B2 (de)
AT (1) ATE191088T1 (de)
AU (1) AU658890B2 (de)
CA (1) CA2071016C (de)
DE (1) DE69230812T2 (de)
ES (1) ES2144411T3 (de)
FR (1) FR2677767B1 (de)
NZ (1) NZ243112A (de)
PT (1) PT518756E (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2677666B1 (fr) * 1991-06-11 1994-08-12 Biotechnologie Ste Europ Peptides ou polypeptides immunogenes du virus bvd et virus apparentes, vaccins les incorporant ou les exprimant, procedes et moyens de production y relatifs.
US6174667B1 (en) 1997-09-23 2001-01-16 Cornell Research Foundation, Inc. Bovine viral diarrhea virus serum antigen capture
DE19848937A1 (de) * 1998-10-23 2000-05-11 Hoechst Roussel Vet Gmbh Verfahren zum Nachweis der Erreger der bovinen Virusdiarrhoe sowie Testkit zu dessen Durchführung
US6168942B1 (en) 1998-11-10 2001-01-02 Pfizer Inc. Attenuated forms of bovine viral diarrhea virus
KR100331176B1 (ko) * 1999-12-15 2002-04-06 대한민국(관리청:특허청장, 승계청:국립수의과학검역원장) 재조합 단백질을 항원으로 이용한 소 바이러스성 설사증의진단방법
AU2002365248A1 (en) 2001-08-09 2003-09-02 Cornell Research Foundation, Inc. Detection of bovine viral diarrhea virus in hair samples
ATE354681T1 (de) 2001-08-09 2007-03-15 Idexx Lab Inc Nachweis des virus der viralen rinderdiarrhoe in gewebsproben
US7977098B2 (en) 2002-05-31 2011-07-12 Children's Hospital Medical Center Antigenic binding patterns of norovirus to human histo-blood group antigens
WO2003101176A2 (en) * 2002-05-31 2003-12-11 Children's Hospital Medical Center Method, composition and kit for antigenic binding of norwalk-like viruses
US20110152263A1 (en) * 2006-11-16 2011-06-23 Xi Jiang Composition and method for inhibiting norovirus infection
US8486421B2 (en) 2009-06-09 2013-07-16 Children's Hospital Medical Center Antigen-norovirus P-domain monomers and dimers, antigen-norovirus P-particle molecules, and methods for their making and use
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
US9321803B2 (en) 2013-07-12 2016-04-26 Children's Hospital Medical Center Compositions and methods for inhibiting norovirus infection
EP3600397A4 (de) 2017-03-28 2021-01-27 Children's Hospital Medical Center Impfstoffe auf basis von norovirus-s-partikeln sowie verfahren zur herstellung und verwendung davon
CN109374887A (zh) * 2018-10-12 2019-02-22 北京纳百生物科技有限公司 牛病毒性腹泻病毒抗原胶体金检测试剂盒及其应用
CN110093429B (zh) * 2019-01-30 2022-10-28 浙江正合谷生物科技有限公司 一种腹泻性致病菌的高通量定量检测试剂盒

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4391904A (en) * 1979-12-26 1983-07-05 Syva Company Test strip kits in immunoassays and compositions therein
ZA864879B (en) * 1985-07-08 1987-03-25 Wallone Region Vaccines and diagnostics derived from boving diarrhoea virus
US5206163A (en) * 1985-07-08 1993-04-27 Chiron Corporation DNA encoding bovine diarrhea virus protein
US5041385A (en) * 1986-11-01 1991-08-20 Oxford Gene Systems Limited Vector expressing fusion proteins and particles
FR2677666B1 (fr) * 1991-06-11 1994-08-12 Biotechnologie Ste Europ Peptides ou polypeptides immunogenes du virus bvd et virus apparentes, vaccins les incorporant ou les exprimant, procedes et moyens de production y relatifs.

Also Published As

Publication number Publication date
FR2677767A1 (fr) 1992-12-18
EP0518756B1 (de) 2000-03-22
JP3415635B2 (ja) 2003-06-09
FR2677767B1 (fr) 1994-10-14
EP0518756A1 (de) 1992-12-16
US5648466A (en) 1997-07-15
NZ243112A (en) 1994-09-27
JPH05297005A (ja) 1993-11-12
DE69230812T2 (de) 2000-07-27
US5665534A (en) 1997-09-09
PT518756E (pt) 2000-08-31
CA2071016A1 (en) 1992-12-12
ES2144411T3 (es) 2000-06-16
AU1814692A (en) 1992-12-17
CA2071016C (en) 2007-04-10
AU658890B2 (en) 1995-05-04
DE69230812D1 (de) 2000-04-27

Similar Documents

Publication Publication Date Title
ATE191088T1 (de) Verfahren zum nachweis einer rinderdiarrhoe- virusinfektion, für ein durch eine infektion mit diesem virus induziertes eiweiss kodierende nukleotidsequenz, sowie daraus abgeleitete rekombinante eiweisse und antigene
ATE144993T1 (de) Synthetische antigene zum nachweis von antikörpern gegen hepatitis c-virus
DE69131707D1 (de) Nachweis von Hepatits C mit Verwendung rekombinanter Antigene
DE69230917D1 (de) Verfahren zur detektion von hepatitis c
KR930016439A (ko) 시이엔피-비(cenp-b)항원 결정부
WO1995032292A3 (en) Detection of viral antigens coded by reverse-reading frames
KR940005666A (ko) C형 간염 바이러스를 분류하기 위한 항원성 펩티드 ,이 펩티드를 포함하는 키트 및 이 펩티드를 사용하여 c형 간염 바이러스를 분류하는 방법
Philipson et al. Interaction between poliovirus and immunoglobulins: I. Detection of virus antibodies by partition in aqueous polymer phase systems
DE69028561D1 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
DE69231719D1 (de) Diagnostisches Reagenz für Hepatitis C
DE69119445D1 (de) Analysemethode für infektiöse Pferdeanämie-Viren (EIA-Virus)
KR950704353A (ko) 씨(c)형 간염 비루스(hcv) 비-구조-3 펩티드, 그에 대한 항체 및 에이취씨브이(hcv)의 검출 방법(hepatitis c virus(hcv) non-structurac-3 peptides, antibodies thereto and methods for the detection of hcv)
DK142488A (da) Treponema hyodysenteriae antigener, vaccine indeholdende disse antigener eller fragmenter deraf og metode til bestemmelse af antistoffer over for treponema hyodysenteriae
EP0949333A4 (de) Mutierte antigene des masernvirus und die dafür kodierenden gene.
SG145521A1 (en) Synthetic antigens for the detection of antibodies to hepatitis c virus
CA2074370A1 (en) Synthetic antigens for the detection of antibodies to hepatitis c virus
DE69133609D1 (de) Asialoglykoproteine von Hepatitis C virus

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification